The consensus price target hints at a 35.7% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings est
Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript
WASHINGTON , Feb. 22, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make
WASHINGTON , Feb. 14, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make
Company to Participate in Upcoming Investor Conferences   WASHINGTON , Jan. 25, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people

New Strong Buy Stocks for January 5th

08:16am, Friday, 05'th Jan 2024
ORGO, CALM, W, NET and EVH have been added to the Zacks Rank #1 (Strong Buy) List on January 5, 2024.
The consensus price target hints at a 59.7% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings est
WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make h
WASHINGTON , Dec. 5, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make h
The average of price targets set by Wall Street analysts indicates a potential upside of 56.8% in Evolent Health (EVH). While the effectiveness of this highly sought-after metric is questionable, the

Best Momentum Stocks to Buy for November 20th

11:17am, Monday, 20'th Nov 2023
EVH, ACGL and AREC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 20, 2023.
Evolent Health, Inc. (NYSE:EVH ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Offic
Evolent Health (EVH) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.59 per share a year ago.

Evolent Announces Third Quarter 2023 Results

04:10pm, Thursday, 02'nd Nov 2023
WASHINGTON , Nov. 2, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make h
WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE